Companies
Company Logo
Oneliner
Company Logo
Oneliner
Add Entity
snc-logo

Startup Nation Finder

Ecosystem
Startups
Investors
Hubs
Multinationals
Reports toggle reports submenu
My Watchlists
My Saved Searches
Following
Inbox
About Us
Glossary

snackbar-icon
title

Your CSV is on the way

We’ve sent your CSV file to
send file

Provide your business email

To complete this action, please provide your Business email.

Verify your business email

You only need to verify it once.
We’ve sent a verification link to

Create new Watchlist

Watchlist name*
Watchlist must have a valid name.
Description (optional)
Notifications Off
Public content (accessible by all Finder users)

Add to watchlist

    Hey #USER_FULLNAME#!
    Claim #COMPANY_NAME#’s profile to become an administrator with editing privileges in
    #COMPANY_NAME#’s page on Startup Nation Finder

    The invitation to claim the profile was originally sent to

    or  

    Hey #USER_FULLNAME#!
    Claim #COMPANY_NAME#’s profile to become an administrator with editing privileges in
    #COMPANY_NAME#’s page on Startup Nation Finder

    Suggest Edits

    Let us know what you think is inaccurate or missing.
    We will check it out and update the profile if needed.

    Claim Profile

    Please provide us the following information. Note that you need to have an email in this organization in order to claim the profile.

    Already have an account? Login

    Verify your email

    We’ve sent a verification link to [email protected]
    Reset password
    Don't have an account? Sign up

    Check your mailbox

    We sent you an email with further instructions to
    [email protected]

    Do not forget to check your spam folder

    Didn’t get the email? Resend email or Contact us

    Password must contain at least 8 characters, one digit, one uppercase and one lowercase letter.

    Save Search

    Search must have a valid name.

    Rename Search

    Search must have a valid name.
    Delete Saved Search Confirmation
    search will be permanently removed from Finder.
    News Analysis
    disclaimer-icon
    Summary generated by AI
    Read article
    Search Startups

    Stage Acquired and Stage Pre-Funding, Tagged as ('biopharmaceutical') Startups

    Filters
    Clear

    Search by tag (1)

    All of
    Any of
    None of

    Sector 

    Primary Sector 

    Target Customer 

    Core Technology 

    Funding Stage (2)

    Founded 

    Total Raised 

    Min
    Max

    Market Cap 

    Min
    Max

    Business Models 

    Product Stage 

    Employees 

    Location 

    Status 
    38 Startups 0 In the News 1 Recently Updated
    • Total Funding
      $265.73M
      Raised
      15
      Events
    • Private Funding
      $158.93M
      Raised
      9
      Rounds
    • Public Offerings
      $0
      Raised
      0
      Offerings
    • M&A
      $106.8M
      Raised
      6
      Deals
    Funding
    Number of Employees
    Rounds / Deals
    Funding Stage
    Tags

    There aren’t any companies that match your search
    you can try looking for something else.

    ActiViews logo

    ActiViews

    Presumed Inactive
    ?
    Based on data collected from different sources by our team,
    there are indicators that suggest that this company is no longer active. However, this information may not be accurate. If you believe this information should be updated, please .
    For more details, you can read our .
    CT-guided Lung Biopsy Device
    2006 B2B 1-10 Acquired $10M
    video
    software-applications
    diagnostics
    pulmonary
    biopharmaceutical
    hospitals
    surgical-instruments
    ct-scan
    medical-devices
    AEBi logo

    AEBi

    Therapeutic Peptides for Personalized Cancer Treatment
    2000 B2B 1-10 Pre-Funding Undisclosed
    drug-development
    drug-discovery
    biopharmaceutical
    pharma-companies
    patent-pending
    screening
    pharmaceuticals
    personalized-medicine
    cancer
    Allosterix Pharmaceuticals logo

    Allosterix Pharmaceuticals

    Presumed Inactive
    ?
    Based on data collected from different sources by our team,
    there are indicators that suggest that this company is no longer active. However, this information may not be accurate. If you believe this information should be updated, please .
    For more details, you can read our .
    Developing Highly Selective Peptide-based Inhibitors
    2007 B2B 1-10 Pre-Funding Undisclosed
    drug-design
    biopharmaceutical
    pharma-companies
    laboratories
    ApoRx Biopharmaceuticals logo

    ApoRx Biopharmaceuticals

    Targeted Protein Degradation Drug Discovery
    2021 B2B 1-10 Pre-Funding Undisclosed
    oncology
    pharmaceuticals
    immunotherapy
    pharma-companies
    biotechnology
    drug-discovery
    drug-design
    biopharmaceutical
    cancer-therapy
    cancer
    Applied Immune Technologies logo

    Applied Immune Technologies

    Presumed Inactive
    ?
    Based on data collected from different sources by our team,
    there are indicators that suggest that this company is no longer active. However, this information may not be accurate. If you believe this information should be updated, please .
    For more details, you can read our .
    TCRL Antibodies for Therapeutic Applications
    2006 B2B 1-10 Acquired $4.4M
    viral-diseases
    cancer
    antibodies
    biotechnology
    biopharmaceutical
    therapeutics
    diagnostics
    autoimmune-diseases
    patients
    doctors
    Aspireo Pharmaceuticals logo

    Aspireo Pharmaceuticals

    Presumed Inactive
    ?
    Based on data collected from different sources by our team,
    there are indicators that suggest that this company is no longer active. However, this information may not be accurate. If you believe this information should be updated, please .
    For more details, you can read our .
    Treatments for Conditions Resulting from Hormone-active Tumors
    2010 B2B 1-10 Pre-Funding Undisclosed
    cancer
    infectious-disease
    medical-technologies
    biopharmaceutical
    treatments
    BARcure logo

    BARcure

    Presumed Inactive
    ?
    Based on data collected from different sources by our team,
    there are indicators that suggest that this company is no longer active. However, this information may not be accurate. If you believe this information should be updated, please .
    For more details, you can read our .
    Novel Therapeutic Approach for the Treatment of B-cell Malignancies
    2017 B2B 1-10 Pre-Funding Undisclosed
    biopharmaceutical
    immunology
    therapeutics
    drug-delivery
    cancer
    pharmaceuticals
    immuno-theraphy
    oncology
    immunotherapy

    Notifications settings

    Off
    Frequency:
    Select all

    Search Startups

    38 Results
    Funding Amount
    Funding Stages
    • Total Funding
      $265.73M
      Raised
      15
      Events
    • Private Funding
      $158.93M
      Raised
      9
      Rounds
    • Public Offerings
      $0
      Raised
      0
      Offerings
    • M&A
      $106.8M
      Raised
      6
      Deals

    Funding

    Rounds / Deals

    Funding Stage

    Number of Employees

    There aren’t any companies that match your search
    you can try looking for something else.

    ActiViews logo
    Raised
    $10M
    ActiViews
    Presumed Inactive
    ?
    Based on data collected from different sources by our team,
    there are indicators that suggest that this company is no longer active. However, this information may not be accurate. If you believe this information should be updated, please .
    For more details, you can read our .
    CT-guided Lung Biopsy Device
    Founded:2006
    Business Model:B2B
    Employees:1-10
    Funding Stage:Acquired
    AEBi logo
    Raised
    Undisclosed
    AEBi
    Therapeutic Peptides for Personalized Cancer Treatment
    Founded:2000
    Business Model:B2B
    Employees:1-10
    Funding Stage:Pre-Funding
    Allosterix Pharmaceuticals logo
    Raised
    Undisclosed
    Allosterix Pharmaceuticals
    Presumed Inactive
    ?
    Based on data collected from different sources by our team,
    there are indicators that suggest that this company is no longer active. However, this information may not be accurate. If you believe this information should be updated, please .
    For more details, you can read our .
    Developing Highly Selective Peptide-based Inhibitors
    Founded:2007
    Business Model:B2B
    Employees:1-10
    Funding Stage:Pre-Funding
    ApoRx Biopharmaceuticals logo
    Raised
    Undisclosed
    ApoRx Biopharmaceuticals
    Targeted Protein Degradation Drug Discovery
    Founded:2021
    Business Model:B2B
    Employees:1-10
    Funding Stage:Pre-Funding
    Applied Immune Technologies logo
    Raised
    $4.4M
    Applied Immune Technologies
    Presumed Inactive
    ?
    Based on data collected from different sources by our team,
    there are indicators that suggest that this company is no longer active. However, this information may not be accurate. If you believe this information should be updated, please .
    For more details, you can read our .
    TCRL Antibodies for Therapeutic Applications
    Founded:2006
    Business Model:B2B
    Employees:1-10
    Funding Stage:Acquired
    Aspireo Pharmaceuticals logo
    Raised
    Undisclosed
    Aspireo Pharmaceuticals
    Presumed Inactive
    ?
    Based on data collected from different sources by our team,
    there are indicators that suggest that this company is no longer active. However, this information may not be accurate. If you believe this information should be updated, please .
    For more details, you can read our .
    Treatments for Conditions Resulting from Hormone-active Tumors
    Founded:2010
    Business Model:B2B
    Employees:1-10
    Funding Stage:Pre-Funding
    BARcure logo
    Raised
    Undisclosed
    BARcure
    Presumed Inactive
    ?
    Based on data collected from different sources by our team,
    there are indicators that suggest that this company is no longer active. However, this information may not be accurate. If you believe this information should be updated, please .
    For more details, you can read our .
    Novel Therapeutic Approach for the Treatment of B-cell Malignancies
    Founded:2017
    Business Model:B2B
    Employees:1-10
    Funding Stage:Pre-Funding
    Unlock financial data
    Finder is provided for free by the non-profit organization Startup Nation Central.
    • Get unlimited search results
    • Save to custom lists - Watchlists
    • Get notified with news and updates
    • Connect with people
    And much more...
    I already have access,
    I already have access,